Madrigal Pharmaceuticals
MDGL
84 hedge funds and large institutions have $146M invested in Madrigal Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 39 increasing their positions, 26 reducing their positions, and 13 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 26
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less funds holding
Funds holding: 92 → 84 (-8)
12% less capital invested
Capital invested by funds: $167M → $146M (-$20.7M)
42% less call options, than puts
Call options by funds: $786K | Put options by funds: $1.35M
54% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.46M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.22M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.1M |
| 4 |
Morgan Stanley
New York
|
+$960K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$858K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JG
Jefferies Group
New York
|
-$2.71M |
| 2 |
Goldman Sachs
New York
|
-$1.14M |
| 3 |
D.E. Shaw & Co
New York
|
-$975K |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$809K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$447K |
MDGL Hedge Fund Activity: Q4 2014 in Review
84 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Madrigal Pharmaceuticals (MDGL) for Q4 2014, worth a combined $146M — down 12% from $167M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of MDGL and 6 opened new positions — a net loss of 7 holders — while 26 trimmed existing stakes and 39 added.
The largest buyer was Millennium Management, adding an estimated $1.46M. The largest seller was Jefferies Group, exiting entirely with an estimated $2.71M sold.
- 84 institutional investors held Madrigal Pharmaceuticals (MDGL) as of Q4 2014, down from 92 in Q3 2014.
- Funds reported $146M of Madrigal Pharmaceuticals stock for Q4 2014, down 12% quarter-over-quarter.
- 6 funds opened new Madrigal Pharmaceuticals positions in Q4 2014 and 13 closed out, a net change of -7 holders.
- The largest Madrigal Pharmaceuticals buyer in Q4 2014 was Millennium Management, an estimated $1.46M added.
- The largest Madrigal Pharmaceuticals seller in Q4 2014 was Jefferies Group, an estimated $2.71M sold.
Based on aggregated 13F filings for Q4 2014.